GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Athersys Inc (OTCPK:ATHXQ) » Definitions » E10

Athersys (Athersys) E10 : $-1.31 (As of Sep. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Athersys E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Athersys's adjusted earnings per share data for the three months ended in Sep. 2023 was $-0.150. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.31 for the trailing ten years ended in Sep. 2023.

During the past 3 years, the average E10 Growth Rate was -41.50% per year. During the past 5 years, the average E10 Growth Rate was -12.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Athersys was 65.60% per year. The lowest was -41.50% per year. And the median was 11.40% per year.

As of today (2024-05-27), Athersys's current stock price is $0.0049. Athersys's E10 for the quarter that ended in Sep. 2023 was $-1.31. Athersys's Shiller PE Ratio of today is .


Athersys E10 Historical Data

The historical data trend for Athersys's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Athersys E10 Chart

Athersys Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.47 -0.42 -0.39 -0.56 -1.19

Athersys Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.12 -1.19 -1.23 -1.29 -1.31

Competitive Comparison of Athersys's E10

For the Biotechnology subindustry, Athersys's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Athersys's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Athersys's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Athersys's Shiller PE Ratio falls into.



Athersys E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Athersys's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.15/129.8595*129.8595
=-0.150

Current CPI (Sep. 2023) = 129.8595.

Athersys Quarterly Data

per share eps CPI Adj_EPS
201312 -0.150 98.326 -0.198
201403 -0.150 99.695 -0.195
201406 -0.040 100.560 -0.052
201409 -0.080 100.428 -0.103
201412 -0.080 99.070 -0.105
201503 -0.160 99.621 -0.209
201506 -0.050 100.684 -0.064
201509 -0.080 100.392 -0.103
201512 0.040 99.792 0.052
201603 0.060 100.470 0.078
201606 -0.080 101.688 -0.102
201609 -0.070 101.861 -0.089
201612 -0.100 101.863 -0.127
201703 -0.060 102.862 -0.076
201706 -0.060 103.349 -0.075
201709 -0.060 104.136 -0.075
201712 -0.110 104.011 -0.137
201803 -0.080 105.290 -0.099
201806 0.050 106.317 0.061
201809 -0.070 106.507 -0.085
201812 -0.080 105.998 -0.098
201903 -0.090 107.251 -0.109
201906 -0.060 108.070 -0.072
201909 -0.080 108.329 -0.096
201912 -0.060 108.420 -0.072
202003 -0.100 108.902 -0.119
202006 -0.100 108.767 -0.119
202009 -0.110 109.815 -0.130
202012 -0.110 109.897 -0.130
202103 -0.130 111.754 -0.151
202106 -0.100 114.631 -0.113
202109 -1.760 115.734 -1.975
202112 -0.090 117.630 -0.099
202203 -2.270 121.301 -2.430
202206 -2.280 125.017 -2.368
202209 -1.150 125.227 -1.193
202212 -0.830 125.222 -0.861
202303 -0.430 127.348 -0.438
202306 -0.620 128.729 -0.625
202309 -0.150 129.860 -0.150

Add all the adjusted EPS together and divide 10 will get our e10.


Athersys  (OTCPK:ATHXQ) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Athersys E10 Related Terms

Thank you for viewing the detailed overview of Athersys's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Athersys (Athersys) Business Description

Traded in Other Exchanges
N/A
Address
3201 Carnegie Avenue, Cleveland, OH, USA, 44115-2634
Athersys Inc is a biotechnology company engaged in the field of regenerative medicine. It consists of research, clinical development, manufacturing, and manufacturing process development activities. The firm's main product is Multistem cell therapy. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.
Executives
Neema Mayhugh director 3201 CARNEGIE AVE, CLEVELAND OH 44115
Joseph Patrick Nolan director 100 PARK LANE, LAKE BLUFF IL 60044
Daniel A. Camardo director, officer: Chief Executive Officer ATHERSYS, INC., 3201 CARNEGIE AVE, CLEVELAND OH 44115
Maia Hansen officer: Chief Operating Officer 16430 N. SCOTTSDALE ROAD, SCOTTSDALE AZ 85254
Kasey Rosado officer: Interim, CFO 485 LEXINGTON AVE 10TH FLOOR, NEW YORK NY 10017
Ismail Kola director 3201 CARNEGIE AVENUE, CLEVELAND OH 44115
Ivor Macleod officer: Chief Financial Officer 3201 CARNEGIE AVENUE, CLEVELAND OH 44115-2634
William Jr Lehmann officer: President 3201 CARNEGIE AVENUE, CLEVELAND OH 44115
John J Harrington director, officer: Chief Scientific Officer 3201 CARNEGIE AVENUE, CLEVELAND OH 44115
Laura K Campbell officer: Vice President 3201 CARNEGIE AVENUE, CLEVELAND OH 44115
Katherine Bach Kalin director 3201 CARNEGIE AVENUE, CLEVELAND OH 44115
Baiju R. Shah director ONE INVACARE WAY, ELYRIA OH 44035
Jane Wasman director C/O ACORDA THERAPEUTICS, INC., 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502
Kenneth H Traub director
Tadahisa Kagimoto director, 10 percent owner HEALIOS K.K., WORLD TRADE CENTER BLDG., 15F, 2-4-1 HAMAMATSUCHO, MINATO-KU, TOKYO M0 1056115

Athersys (Athersys) Headlines